Catheter Precision (VTAK) Asset Writedowns and Impairment (2018 - 2023)

Catheter Precision (VTAK) has 4 years of Asset Writedowns and Impairment data on file, last reported at -$4.8 million in Q4 2023.

• On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$4.8 million in Q4 2023; TTM through Sep 2023 was $5.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $7.0 million, changed N/A from the prior year.
• Asset Writedowns and Impairment for Q4 2023 stood at -$4.8 million, up from -$56.1 million in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for VTAK reached as high as $56.1 million in Q1 2023 and fell as low as -$56.1 million in Q3 2023.
• Historically, Asset Writedowns and Impairment has averaged $46300.0 across 3 years, with a median of $20500.0 in 2019.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 811.76% in 2020 and fell as far as 95.87% in 2020.
• Year by year, Asset Writedowns and Impairment stood at $17000.0 in 2019, then jumped by 811.76% to $155000.0 in 2020, then plunged by 3196.77% to -$4.8 million in 2023.
• Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$4.8 million in Q4 2023, -$56.1 million in Q3 2023, and $4.8 million in Q2 2023.